Drug Side Effects

CETIRIZINE

CETIRIZINE was reported 163684 times

These side effects are most commonly reported by patients taking CETIRIZINE:

# Side effect Count
0 DRUG INEFFECTIVE 13508
1 FATIGUE 13440
2 PAIN 12536
3 RASH 10265
4 OFF LABEL USE 9972
5 ABDOMINAL DISCOMFORT 9641
6 ALOPECIA 9534
7 RHEUMATOID ARTHRITIS 8996
8 SYSTEMIC LUPUS ERYTHEMATOSUS 8763
9 PEMPHIGUS 8559
10 SWELLING 8196
11 HYPERSENSITIVITY 8046
12 GLOSSODYNIA 8025
13 HEADACHE 7893
14 PRURITUS 7886
15 ARTHRALGIA 7875
16 DYSPNOEA 7630
17 JOINT SWELLING 7295
18 INFUSION RELATED REACTION 7273
19 NAUSEA 7132
20 HAND DEFORMITY 7034
21 ARTHROPATHY 6983
22 WOUND 6786
23 CONTRAINDICATED PRODUCT ADMINISTERED 6634
24 PERICARDITIS 6432
25 PYREXIA 6420
26 DRUG INTOLERANCE 6395
27 HEPATIC ENZYME INCREASED 6378
28 DIARRHOEA 6367
29 SYNOVITIS 6152
30 URTICARIA 6063
31 MATERNAL EXPOSURE DURING PREGNANCY 6062
32 DISCOMFORT 5881
33 CONDITION AGGRAVATED 5857
34 VOMITING 5742
35 PRODUCT USE ISSUE 5523
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5438
37 MALAISE 5432
38 PERIPHERAL SWELLING 5308
39 DIZZINESS 5281
40 NASOPHARYNGITIS 5183
41 WEIGHT INCREASED 5163
42 DUODENAL ULCER PERFORATION 4993
43 BLISTER 4935
44 HELICOBACTER INFECTION 4932
45 HYPERTENSION 4907
46 INFECTION 4788
47 CONFUSIONAL STATE 4753
48 LOWER RESPIRATORY TRACT INFECTION 4583
49 SINUSITIS 4556
50 GENERAL PHYSICAL HEALTH DETERIORATION 4550
51 STOMATITIS 4376
52 THERAPEUTIC PRODUCT EFFECT DECREASED 4348
53 FOLLICULITIS 4331
54 IMPAIRED HEALING 4312
55 IRRITABLE BOWEL SYNDROME 4251
56 TREATMENT FAILURE 4183
57 ABDOMINAL PAIN UPPER 4031
58 INSOMNIA 4031
59 DRUG HYPERSENSITIVITY 3998
60 ASTHENIA 3874
61 MUSCLE INJURY 3831
62 PNEUMONIA 3807
63 GASTROINTESTINAL DISORDER 3793
64 TYPE 2 DIABETES MELLITUS 3743
65 PSORIATIC ARTHROPATHY 3690
66 HYPOAESTHESIA 3678
67 INTENTIONAL PRODUCT USE ISSUE 3619
68 MUSCULOSKELETAL STIFFNESS 3603
69 ASTHMA 3526
70 ILL-DEFINED DISORDER 3481
71 CONTUSION 3440
72 WHEEZING 3429
73 RHEUMATOID FACTOR POSITIVE 3410
74 MOBILITY DECREASED 3375
75 PRODUCT USE IN UNAPPROVED INDICATION 3350
76 ANXIETY 3293
77 BLOOD CHOLESTEROL INCREASED 3291
78 FIBROMYALGIA 3222
79 INJURY 3123
80 PAIN IN EXTREMITY 3121
81 RHEUMATIC FEVER 3085
82 LIVER INJURY 3048
83 DECREASED APPETITE 3015
84 SLEEP DISORDER 2986
85 DEPRESSION 2947
86 CHEST PAIN 2793
87 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2758
88 WEIGHT DECREASED 2737
89 EXPOSURE DURING PREGNANCY 2689
90 DRY MOUTH 2685
91 ABDOMINAL PAIN 2683
92 MIGRAINE 2640
93 MEMORY IMPAIRMENT 2504
94 COUGH 2501
95 PARAESTHESIA 2398
96 MUSCLE SPASMS 2361
97 DYSPEPSIA 2349
98 MUSCULAR WEAKNESS 2299
99 SWOLLEN JOINT COUNT INCREASED 2278
100 BACK PAIN 2266
101 INFLAMMATION 2211
102 OSTEOARTHRITIS 2197
103 OEDEMA 2181
104 JOINT RANGE OF MOTION DECREASED 2161
105 BURSITIS 2146
106 GAIT DISTURBANCE 2115
107 FALL 2058
108 ERYTHEMA 2011
109 NIGHT SWEATS 1975
110 GAIT INABILITY 1959
111 LUNG DISORDER 1871
112 PRESCRIBED OVERDOSE 1811
113 FACET JOINT SYNDROME 1804
114 LIP DRY 1804
115 WOUND INFECTION 1720
116 SOMNOLENCE 1703
117 HYPERHIDROSIS 1698
118 COVID-19 1671
119 OBESITY 1666
120 C-REACTIVE PROTEIN ABNORMAL 1662
121 AMNESIA 1661
122 C-REACTIVE PROTEIN INCREASED 1660
123 MUSCULOSKELETAL PAIN 1653
124 CONSTIPATION 1651
125 PRODUCT DOSE OMISSION ISSUE 1614
126 HYPERCHOLESTEROLAEMIA 1597
127 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1573
128 OEDEMA PERIPHERAL 1568
129 ROAD TRAFFIC ACCIDENT 1564
130 GASTROOESOPHAGEAL REFLUX DISEASE 1552
131 ADVERSE DRUG REACTION 1542
132 GRIP STRENGTH DECREASED 1515
133 FEELING ABNORMAL 1501
134 BREAST CANCER STAGE III 1486
135 ADVERSE EVENT 1480
136 LIVER DISORDER 1470
137 VISUAL IMPAIRMENT 1444
138 PULMONARY FIBROSIS 1424
139 ANGIOEDEMA 1408
140 LIVE BIRTH 1404
141 SCIATICA 1403
142 KNEE ARTHROPLASTY 1389
143 HIP ARTHROPLASTY 1368
144 PERIPHERAL VENOUS DISEASE 1356
145 TACHYCARDIA 1349
146 LOWER LIMB FRACTURE 1342
147 AUTOIMMUNE DISORDER 1341
148 THERAPY NON-RESPONDER 1325
149 OVERDOSE 1299
150 DEATH 1297
151 DEEP VEIN THROMBOSIS POSTOPERATIVE 1296
152 UPPER RESPIRATORY TRACT INFECTION 1288
153 PSORIASIS 1280
154 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1260
155 EPILEPSY 1244
156 INTENTIONAL PRODUCT MISUSE 1215
157 DELIRIUM 1212
158 HYPOTENSION 1190
159 BLOOD PRESSURE INCREASED 1187
160 HEART RATE INCREASED 1162
161 ARTHRITIS 1161
162 PALPITATIONS 1144
163 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1133
164 CHEST DISCOMFORT 1090
165 PRESCRIBED UNDERDOSE 1040
166 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1035
167 ABDOMINAL DISTENSION 1024
168 COELIAC DISEASE 1019
169 DISLOCATION OF VERTEBRA 1017
170 DRUG-INDUCED LIVER INJURY 1011
171 BLEPHAROSPASM 985
172 DRUG INTERACTION 982
173 NECK PAIN 980
174 TASTE DISORDER 965
175 ACUTE KIDNEY INJURY 961
176 URINARY TRACT INFECTION 959
177 PRODUCT QUALITY ISSUE 935
178 ANAPHYLACTIC REACTION 931
179 MEDICATION ERROR 928
180 LIP SWELLING 915
181 DRY SKIN 904
182 RESPIRATORY DISORDER 896
183 NAIL DISORDER 891
184 EAR INFECTION 888
185 DEHYDRATION 887
186 LIVER FUNCTION TEST INCREASED 887
187 THROMBOCYTOPENIA 887
188 RED BLOOD CELL SEDIMENTATION RATE INCREASED 885
189 BRONCHITIS 882
190 OSTEOPOROSIS 873
191 MYALGIA 867
192 OROPHARYNGEAL PAIN 865
193 ILLNESS 859
194 RASH ERYTHEMATOUS 857
195 FLUID RETENTION 856
196 CROHN^S DISEASE 851
197 INCORRECT DOSE ADMINISTERED 845
198 INFLUENZA 841
199 ANAEMIA 812
200 MACULAR DEGENERATION 812
201 TREMOR 811
202 EAR PAIN 807
203 DISTURBANCE IN ATTENTION 806
204 FEELING HOT 805
205 IMMUNODEFICIENCY 801
206 HALLUCINATION 799
207 HOSPITALISATION 787
208 INJECTION SITE REACTION 785
209 LUPUS VULGARIS 784
210 SWELLING FACE 770
211 JOINT STIFFNESS 767
212 HEPATIC CIRRHOSIS 763
213 EXOSTOSIS 756
214 NASAL CONGESTION 752
215 ONYCHOMADESIS 749
216 DYSPHAGIA 748
217 X-RAY ABNORMAL 737
218 CHILLS 736
219 BLOOD GLUCOSE INCREASED 733
220 LARYNGITIS 727
221 INJECTION SITE PAIN 726
222 PREGNANCY 716
223 COGNITIVE DISORDER 715
224 LOSS OF CONSCIOUSNESS 713
225 BONE EROSION 710
226 FOOT DEFORMITY 709
227 FOOD ALLERGY 704
228 EYE PRURITUS 702
229 UNDERDOSE 697
230 TOXICITY TO VARIOUS AGENTS 695
231 THERAPEUTIC RESPONSE DECREASED 686
232 BACK INJURY 684
233 LUPUS-LIKE SYNDROME 678
234 SEIZURE 672
235 RETINITIS 669
236 CHRONIC KIDNEY DISEASE 660
237 PRODUCTIVE COUGH 659
238 JOINT DISLOCATION 630
239 FOETAL EXPOSURE DURING PREGNANCY 629
240 RHINORRHOEA 629
241 TINNITUS 625
242 MYOCARDIAL INFARCTION 619
243 RECTAL HAEMORRHAGE 615
244 HEPATITIS 601
245 COLITIS ULCERATIVE 600
246 SYNCOPE 599
247 RASH PRURITIC 598
248 STRESS 590
249 FLUSHING 585
250 MUSCLE TWITCHING 582
251 OXYGEN SATURATION DECREASED 579
252 RENAL FAILURE 573
253 THROAT IRRITATION 569
254 BALANCE DISORDER 567
255 ONYCHOMYCOSIS 567
256 FREQUENT BOWEL MOVEMENTS 564
257 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 564
258 C-REACTIVE PROTEIN 563
259 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 562
260 DRUG ABUSE 560
261 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 556
262 NO ADVERSE EVENT 555
263 VISION BLURRED 549
264 BODY TEMPERATURE INCREASED 541
265 FEBRILE NEUTROPENIA 540
266 WALKING AID USER 533
267 ECZEMA 527
268 DISABILITY 523
269 DEPRESSED MOOD 518
270 NEUROPATHY PERIPHERAL 518
271 SUICIDAL IDEATION 518
272 BREAST CANCER STAGE II 507
273 HYPOKALAEMIA 505
274 TRANSIENT ISCHAEMIC ATTACK 501
275 PAIN OF SKIN 488
276 FINGER DEFORMITY 484
277 DIPLOPIA 482
278 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 478
279 FACIAL PAIN 476
280 BLINDNESS 474
281 SUBARACHNOID HAEMORRHAGE 474
282 SLEEP TERROR 468
283 WHITE BLOOD CELL COUNT INCREASED 464
284 ANOSMIA 460
285 NEUTROPENIA 460
286 CONGENITAL ANOMALY 457
287 DRUG TOLERANCE DECREASED 456
288 VASCULITIS 455
289 TEMPERATURE REGULATION DISORDER 447
290 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 443
291 EMOTIONAL DISTRESS 438
292 ALANINE AMINOTRANSFERASE INCREASED 437
293 DYSPHONIA 437
294 AGITATION 430
295 PRURITUS GENITAL 430
296 MUSCLE SPASTICITY 427
297 VENTRICULAR TACHYCARDIA 418
298 TENSION HEADACHE 414
299 PARAESTHESIA ORAL 410
300 PRODUCT LABEL CONFUSION 407
301 SKIN EXFOLIATION 406
302 OBSTRUCTIVE AIRWAYS DISORDER 402
303 ATRIAL TACHYCARDIA 400
304 CARDIOSPASM 397
305 DRY EYE 397
306 SWOLLEN TONGUE 396
307 CAROTID ARTERY OCCLUSION 391
308 HAEMATOCHEZIA 391
309 PANCREATITIS 389
310 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 389
311 BURNING SENSATION 387
312 PALMOPLANTAR KERATODERMA 385
313 BLOOD PRESSURE DECREASED 384
314 VERTIGO 384
315 WITHDRAWAL SYNDROME 384
316 WHITE BLOOD CELL COUNT DECREASED 383
317 ADVERSE REACTION 382
318 DERMATITIS ATOPIC 380
319 ATRIAL FIBRILLATION 379
320 RASH PAPULAR 379
321 MATERNAL EXPOSURE TIMING UNSPECIFIED 375
322 SEPSIS 373
323 ADRENAL INSUFFICIENCY 370
324 EPISTAXIS 369
325 CHRONIC SINUSITIS 367
326 HAEMOGLOBIN DECREASED 367
327 HOT FLUSH 362
328 EXPIRED PRODUCT ADMINISTERED 359
329 PLATELET COUNT DECREASED 359
330 ULCER HAEMORRHAGE 359
331 EYE SWELLING 358
332 BLOOD PRESSURE SYSTOLIC INCREASED 355
333 ASPARTATE AMINOTRANSFERASE INCREASED 351
334 LETHARGY 349
335 DRUG DEPENDENCE 345
336 INJECTION SITE ERYTHEMA 343
337 HYPONATRAEMIA 339
338 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 336
339 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 332
340 MIDDLE INSOMNIA 330
341 PLEURAL EFFUSION 329
342 SERONEGATIVE ARTHRITIS 328
343 INFLUENZA LIKE ILLNESS 327
344 SEASONAL ALLERGY 327
345 SKIN LESION 326
346 DYSPNOEA EXERTIONAL 320
347 BLOOD CREATININE INCREASED 313
348 INTENTIONAL OVERDOSE 313
349 LEUKOPENIA 313
350 RASH MACULAR 312
351 PROCEDURAL PAIN 311
352 COLITIS 307
353 CARDIAC ARREST 305
354 VIRAL INFECTION 299
355 LIMB DISCOMFORT 295
356 RENAL IMPAIRMENT 295
357 CATARACT 293
358 INFUSION SITE REACTION 293
359 IRRITABILITY 293
360 AGGRESSION 292
361 THROAT TIGHTNESS 292
362 CYTOKINE RELEASE SYNDROME 289
363 SUICIDE ATTEMPT 285
364 DIABETES MELLITUS 281
365 DRUG TOLERANCE 281
366 ACCIDENTAL OVERDOSE 279
367 BACK DISORDER 279
368 INJECTION SITE SWELLING 279
369 PULMONARY EMBOLISM 277
370 CELLULITIS 276
371 DYSGEUSIA 276
372 LACRIMATION INCREASED 276
373 EYE PAIN 275
374 FOETAL DEATH 275
375 RESPIRATORY FAILURE 275
376 RESPIRATORY TRACT INFECTION 272
377 PORPHYRIA ACUTE 271
378 CEREBROVASCULAR ACCIDENT 269
379 GASTROENTERITIS VIRAL 268
380 HAEMORRHAGE 268
381 BRADYCARDIA 267
382 LABORATORY TEST ABNORMAL 267
383 COMPLETED SUICIDE 266
384 DISEASE PROGRESSION 265
385 EOSINOPHILIA 265
386 SINUS DISORDER 259
387 MYOSITIS 258
388 ORAL CANDIDIASIS 258
389 BONE PAIN 257
390 NIGHTMARE 256
391 HERPES ZOSTER 255
392 IMMUNISATION 255
393 EYE IRRITATION 253
394 RASH VESICULAR 251
395 SEPTIC SHOCK 251
396 SPEECH DISORDER 251
397 THERAPEUTIC RESPONSE SHORTENED 251
398 THERAPY INTERRUPTED 247
399 ANAPHYLACTIC SHOCK 245
400 RASH MACULO-PAPULAR 243
401 HEART RATE DECREASED 242
402 NEPHROLITHIASIS 242
403 SNEEZING 242
404 BLOOD PRESSURE FLUCTUATION 241
405 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 239
406 COORDINATION ABNORMAL 238
407 CARDIAC FAILURE 236
408 DISORIENTATION 236
409 SKIN DISCOLOURATION 233
410 SLEEP APNOEA SYNDROME 233
411 EXTRA DOSE ADMINISTERED 231
412 NORMAL NEWBORN 231
413 TREATMENT NONCOMPLIANCE 231
414 DYSARTHRIA 229
415 DISEASE RECURRENCE 228
416 OCULAR HYPERAEMIA 228
417 PUSTULAR PSORIASIS 227
418 CARDIAC DISORDER 225
419 SCRATCH 225
420 JOINT INJURY 224
421 INJECTION SITE PRURITUS 223
422 MUCOSAL INFLAMMATION 221
423 HYPOXIA 220
424 CARDIAC FAILURE CONGESTIVE 219
425 URINARY RETENTION 219
426 DYSURIA 218
427 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 218
428 TEMPERATURE INTOLERANCE 218
429 FLATULENCE 217
430 LYMPHADENOPATHY 217
431 MULTIPLE SCLEROSIS 217
432 SKIN PLAQUE 217
433 THROMBOSIS 217
434 ELECTROCARDIOGRAM QT PROLONGED 215
435 JAUNDICE 214
436 JOINT DESTRUCTION 214
437 SPONDYLITIS 213
438 WEIGHT FLUCTUATION 213
439 COMA 212
440 PANIC ATTACK 211
441 VAGINAL DISCHARGE 211
442 EYE DISORDER 207
443 NERVOUSNESS 207
444 CRYING 206
445 INJECTION SITE BRUISING 206
446 RESTLESSNESS 206
447 ULCER 206
448 POLYARTHRITIS 205
449 PRURITUS GENERALISED 205
450 CHRONIC SPONTANEOUS URTICARIA 202
451 INFUSION SITE PAIN 199
452 HYPOGLYCAEMIA 198
453 GENERAL SYMPTOM 197
454 HYPERKALAEMIA 197
455 ANGER 196
456 ABORTION SPONTANEOUS 195
457 PROCTITIS 195
458 LYMPHOCYTE COUNT DECREASED 194
459 GASTROINTESTINAL HAEMORRHAGE 193
460 RETCHING 192
461 URINARY INCONTINENCE 192
462 BLOOD POTASSIUM DECREASED 191
463 CYSTITIS 191
464 FUNGAL INFECTION 191
465 PANCYTOPENIA 190
466 PRODUCT SUBSTITUTION ISSUE 189
467 RED BLOOD CELL COUNT DECREASED 189
468 HYPERSOMNIA 188
469 RADICULOPATHY 188
470 PRESYNCOPE 186
471 SKIN BURNING SENSATION 186
472 UNEVALUABLE EVENT 185
473 FEMALE GENITAL TRACT FISTULA 184
474 POLLAKIURIA 182
475 INTENTIONAL DOSE OMISSION 180
476 ACNE 179
477 FEELING COLD 179
478 POOR QUALITY SLEEP 177
479 PRODUCT DOSE OMISSION IN ERROR 176
480 SURGERY 175
481 LIMB INJURY 174
482 PHARYNGEAL SWELLING 174
483 BLOOD IMMUNOGLOBULIN E INCREASED 173
484 DRUG WITHDRAWAL SYNDROME 172
485 SINUS CONGESTION 172
486 INCORRECT PRODUCT ADMINISTRATION DURATION 171
487 VAGINAL FLATULENCE 171
488 DRUG DOSE OMISSION 170
489 RHINITIS 170
490 FORCED EXPIRATORY VOLUME DECREASED 169
491 POST-TRAUMATIC STRESS DISORDER 169
492 ANHEDONIA 167
493 APLASTIC ANAEMIA 167
494 DEEP VEIN THROMBOSIS 166
495 MOVEMENT DISORDER 166
496 THERAPEUTIC RESPONSE UNEXPECTED 166
497 CONJUNCTIVITIS 165
498 SPUTUM DISCOLOURED 165
499 EYE INJURY 164
500 IMPAIRED QUALITY OF LIFE 164
501 PHOTOSENSITIVITY REACTION 164
502 BLOOD ALKALINE PHOSPHATASE INCREASED 163
503 HAEMOPTYSIS 163
504 PNEUMONITIS 163
505 HYPOCALCAEMIA 162
506 APHASIA 161
507 PULMONARY OEDEMA 161
508 RENAL DISORDER 161
509 SKIN DISORDER 160
510 SKIN REACTION 160
511 END STAGE RENAL DISEASE 159
512 PHARYNGITIS 159
513 RESPIRATORY TRACT CONGESTION 159
514 DRUG USE DISORDER 158
515 SECRETION DISCHARGE 158
516 HEAD INJURY 157
517 MOUTH ULCERATION 157
518 NODULE 157
519 STEVENS-JOHNSON SYNDROME 157
520 FACE OEDEMA 156
521 FULL BLOOD COUNT ABNORMAL 156
522 ACCIDENTAL EXPOSURE TO PRODUCT 155
523 SPINAL FUSION SURGERY 155
524 DEATH NEONATAL 154
525 ORAL PAIN 154
526 RESTLESS LEGS SYNDROME 154
527 MALIGNANT NEOPLASM PROGRESSION 153
528 MENTAL DISORDER 153
529 THERAPY CESSATION 153
530 ARRHYTHMIA 152
531 AGEUSIA 151
532 DYSKINESIA 150
533 GASTRITIS 149
534 DIVERTICULITIS 148
535 MOOD SWINGS 148
536 MYDRIASIS 148
537 MOOD ALTERED 146
538 BLOOD GLUCOSE DECREASED 145
539 CHROMATURIA 145
540 DRUG EXPOSURE DURING PREGNANCY 145
541 TOXIC EPIDERMAL NECROLYSIS 145
542 BRAIN FOG 144
543 BLOOD PRESSURE DIASTOLIC DECREASED 143
544 BODY TEMPERATURE DECREASED 142
545 DEVICE ISSUE 142
546 SEDATION 142
547 THERAPY PARTIAL RESPONDER 142
548 CONVULSION 140
549 DERMATITIS CONTACT 139
550 ABNORMAL BEHAVIOUR 138
551 HYPERGLYCAEMIA 138
552 HYPOTHYROIDISM 138
553 NEURALGIA 138
554 MULTIPLE ALLERGIES 137
555 ORAL HERPES 136
556 GRIP STRENGTH 135
557 INJECTION SITE HAEMORRHAGE 135
558 RHABDOMYOLYSIS 135
559 BRONCHOSPASM 134
560 DERMATITIS ALLERGIC 134
561 INFUSION SITE ERYTHEMA 134
562 PAIN IN JAW 134
563 SWOLLEN JOINT COUNT 134
564 NEUTROPHIL COUNT DECREASED 133
565 CARDIO-RESPIRATORY ARREST 132
566 DRUG ERUPTION 132
567 GASTROENTERITIS 132
568 MULTIPLE SCLEROSIS RELAPSE 132
569 PALLOR 132
570 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 132
571 VITAMIN D DEFICIENCY 132
572 BLOOD UREA INCREASED 131
573 STAPHYLOCOCCAL INFECTION 131
574 INTESTINAL OBSTRUCTION 130
575 PANCREATITIS ACUTE 130
576 PHOTOPHOBIA 130
577 INTERSTITIAL LUNG DISEASE 129
578 PULMONARY PAIN 129
579 CHOKING 128
580 INTENTIONAL SELF-INJURY 128
581 INTERVERTEBRAL DISC PROTRUSION 127
582 TOOTH FRACTURE 127
583 BLOOD TEST ABNORMAL 126
584 DEPRESSED LEVEL OF CONSCIOUSNESS 126
585 MUSCULOSKELETAL DISCOMFORT 126
586 SKIN HAEMORRHAGE 126
587 TUBULOINTERSTITIAL NEPHRITIS 126
588 CHOLELITHIASIS 125
589 EOSINOPHIL COUNT INCREASED 125
590 FLANK PAIN 125
591 HEAD DISCOMFORT 125
592 HEART RATE IRREGULAR 125
593 IMPAIRED GASTRIC EMPTYING 125
594 NEUTROPHIL COUNT INCREASED 125
595 DEMYELINATION 124
596 PRODUCT AVAILABILITY ISSUE 124
597 PRODUCT DOSE OMISSION 124
598 SKIN IRRITATION 124
599 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 123
600 DRUG EFFECT DECREASED 122
601 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 122
602 UPPER-AIRWAY COUGH SYNDROME 122
603 ACUTE RESPIRATORY FAILURE 121
604 HAEMATOCRIT DECREASED 121
605 INTERVERTEBRAL DISCITIS 121
606 KIDNEY INFECTION 121
607 SPINAL DISORDER 121
608 FEAR 120
609 HYPOMAGNESAEMIA 120
610 UNRESPONSIVE TO STIMULI 119
611 ABNORMAL DREAMS 118
612 APHONIA 118
613 GOUT 118
614 MOUTH SWELLING 118
615 HYPOACUSIS 117
616 PHARYNGEAL OEDEMA 117
617 PRODUCT ADMINISTRATION INTERRUPTED 117
618 CLOSTRIDIUM DIFFICILE INFECTION 116
619 ELECTRIC SHOCK 116
620 GAMMA-GLUTAMYLTRANSFERASE INCREASED 116
621 BLOOD URINE PRESENT 115
622 DEMENTIA 115
623 FOOT FRACTURE 115
624 LIVER FUNCTION TEST ABNORMAL 115
625 OVERLAP SYNDROME 115
626 BREAST CANCER 114
627 HAEMORRHOIDS 114
628 HEPATOCELLULAR INJURY 114
629 INFUSION SITE SWELLING 114
630 PAPULE 114
631 PRODUCT ADMINISTRATION ERROR 114
632 RASH GENERALISED 114
633 THIRST 114
634 OROPHARYNGEAL DISCOMFORT 113
635 RESPIRATORY DISTRESS 113
636 BLOOD CALCIUM DECREASED 112
637 HAEMATOMA 112
638 PARANOIA 112
639 PSYCHOMOTOR HYPERACTIVITY 112
640 DYSSTASIA 111
641 RHINITIS ALLERGIC 111
642 RIB FRACTURE 110
643 BLOOD PRESSURE DIASTOLIC INCREASED 109
644 DRUG EFFECT LESS THAN EXPECTED 109
645 SENSITIVITY TO WEATHER CHANGE 109
646 BLOOD COUNT ABNORMAL 108
647 DECREASED IMMUNE RESPONSIVENESS 108
648 MONOCYTE COUNT INCREASED 108
649 SARS-COV-2 TEST POSITIVE 108
650 BLOOD SODIUM DECREASED 107
651 BONE DENSITY DECREASED 107
652 DERMATITIS 107
653 HEPATIC STEATOSIS 107
654 HYPOAESTHESIA ORAL 107
655 QUALITY OF LIFE DECREASED 107
656 CHOLESTASIS 106
657 LOCALISED INFECTION 106
658 CANDIDA INFECTION 105
659 DYSTONIA 105
660 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 105
661 INSURANCE ISSUE 105
662 PSYCHOTIC DISORDER 105
663 RENAL INJURY 105
664 HALLUCINATION, VISUAL 104
665 INJECTION SITE RASH 104
666 POISONING 104
667 FEEDING DISORDER 103
668 FEELING JITTERY 103
669 SENSORY DISTURBANCE 103
670 EATING DISORDER 101
671 HEPATOTOXICITY 101
672 OSTEOPENIA 101
673 SKIN INFECTION 101
674 SYMPTOM RECURRENCE 101
675 THINKING ABNORMAL 101
676 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 100
677 LACTIC ACIDOSIS 100
678 ANTICIPATORY ANXIETY 99
679 INCREASED APPETITE 99
680 PARKINSON^S DISEASE 99
681 SINUS TACHYCARDIA 99
682 ALTERED STATE OF CONSCIOUSNESS 98
683 GINGIVAL BLEEDING 98
684 MANIA 98
685 WHITE BLOOD CELLS URINE POSITIVE 98
686 HEREDITARY ANGIOEDEMA 97
687 PNEUMONIA ASPIRATION 97
688 SKIN FISSURES 97
689 DEVICE MALFUNCTION 96
690 NEEDLE ISSUE 95
691 PLATELET COUNT INCREASED 95
692 ACCIDENT 94
693 GASTRIC DISORDER 94
694 PRODUCT PRESCRIBING ERROR 94
695 SKIN ULCER 94
696 SOMNAMBULISM 94
697 THROAT CLEARING 94
698 TYPE I HYPERSENSITIVITY 94
699 BRONCHIECTASIS 93
700 CIRCULATORY COLLAPSE 93
701 HYPERTRANSAMINASAEMIA 93
702 PHARYNGITIS STREPTOCOCCAL 93
703 POOR VENOUS ACCESS 93
704 TENDERNESS 93
705 EMOTIONAL DISORDER 92
706 MUSCLE TIGHTNESS 92
707 NERVOUS SYSTEM DISORDER 92
708 CYSTIC FIBROSIS 91
709 HAEMATURIA 91
710 NEOPLASM MALIGNANT 91
711 RESPIRATORY SYNCYTIAL VIRUS INFECTION 91
712 ANKLE FRACTURE 90
713 ARTHROPOD BITE 90
714 BLOOD BILIRUBIN INCREASED 90
715 DRUG EFFECT INCOMPLETE 90
716 HYPOCHOLESTEROLAEMIA 90
717 HYPOPHAGIA 90
718 COVID-19 PNEUMONIA 89
719 MIOSIS 89
720 RESPIRATORY RATE INCREASED 89
721 TRANSAMINASES INCREASED 89
722 ASPIRATION 88
723 CEREBRAL HAEMORRHAGE 88
724 ENCEPHALOPATHY 88
725 LUNG NEOPLASM MALIGNANT 88
726 MAST CELL ACTIVATION SYNDROME 88
727 MELAENA 88
728 SLUGGISHNESS 88
729 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 87
730 FAECES DISCOLOURED 87
731 INJECTION SITE URTICARIA 87
732 PETECHIAE 87
733 TOOTH ABSCESS 87
734 SCAR 86
735 ERECTILE DYSFUNCTION 85
736 GLYCOSYLATED HAEMOGLOBIN INCREASED 85
737 HEPATIC ENZYME 85
738 INJECTION SITE MASS 85
739 NEPHROGENIC ANAEMIA 85
740 TENDONITIS 85
741 ECONOMIC PROBLEM 84
742 BACTERIAL INFECTION 83
743 DECREASED ACTIVITY 83
744 HIATUS HERNIA 83
745 PLASMA CELL MYELOMA 83
746 PULMONARY MASS 83
747 DEAFNESS 82
748 MENTAL STATUS CHANGES 82
749 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82
750 PRODUCT STORAGE ERROR 82
751 RESTRICTIVE PULMONARY DISEASE 82
752 SCAB 82
753 ABDOMINAL PAIN LOWER 81
754 ACUTE MYOCARDIAL INFARCTION 81
755 CARPAL TUNNEL SYNDROME 81
756 GLOMERULAR FILTRATION RATE DECREASED 81
757 MATERNAL EXPOSURE BEFORE PREGNANCY 81
758 ORTHOSTATIC HYPOTENSION 81
759 PERIORBITAL SWELLING 81
760 RHINOVIRUS INFECTION 81
761 VOCAL CORD DYSFUNCTION 81
762 HEPATIC FAILURE 80
763 MASS 80
764 MUSCULOSKELETAL CHEST PAIN 80
765 POST PROCEDURAL COMPLICATION 80
766 SEROTONIN SYNDROME 80
767 TOXIC SKIN ERUPTION 80
768 UPPER LIMB FRACTURE 80
769 VAGINAL HAEMORRHAGE 80
770 ABSCESS 79
771 EAR DISCOMFORT 79
772 HEPATIC CYTOLYSIS 79
773 IMPAIRED WORK ABILITY 79
774 JOINT EFFUSION 79
775 LYMPHOPENIA 79
776 NONINFECTIVE GINGIVITIS 79
777 PRE-EXISTING CONDITION IMPROVED 79
778 TOOTH INFECTION 79
779 ANGIOPATHY 78
780 ERYTHEMA MULTIFORME 78
781 GENERALISED TONIC-CLONIC SEIZURE 78
782 GLAUCOMA 78
783 LARYNGEAL STENOSIS 78
784 URINE ABNORMALITY 78
785 VITAMIN B12 DEFICIENCY 78
786 COLD SWEAT 77
787 FRUSTRATION TOLERANCE DECREASED 77
788 HEPATIC FUNCTION ABNORMAL 77
789 LABYRINTHITIS 77
790 LIGAMENT SPRAIN 77
791 PROCTALGIA 77
792 PULMONARY HYPERTENSION 77
793 BLOOD PRESSURE SYSTOLIC DECREASED 76
794 FOOT OPERATION 76
795 INFUSION SITE HAEMORRHAGE 76
796 ORAL PRURITUS 76
797 PERIPHERAL COLDNESS 76
798 UROSEPSIS 76
799 AFFECTIVE DISORDER 75
800 ANGINA PECTORIS 75
801 ATTENTION DEFICIT HYPERACTIVITY DISORDER 75
802 BLOOD MAGNESIUM DECREASED 75
803 BLOOD POTASSIUM INCREASED 75
804 DIZZINESS POSTURAL 75
805 GALLBLADDER DISORDER 75
806 HIP FRACTURE 75
807 HYPOKINESIA 75
808 INFUSION SITE PRURITUS 75
809 INTERNATIONAL NORMALISED RATIO INCREASED 75
810 OSTEONECROSIS 75
811 RENAL FAILURE ACUTE 75
812 BLOOD PRESSURE ABNORMAL 74
813 DRY THROAT 74
814 FULL BLOOD COUNT DECREASED 74
815 PULMONARY CONGESTION 74
816 TACHYPNOEA 74
817 EMPHYSEMA 73
818 HYPERTHERMIA 73
819 MICTURITION URGENCY 73
820 PURPURA 73
821 TOOTH DISORDER 73
822 BREATH SOUNDS ABNORMAL 72
823 DELUSION 72
824 GASTROINTESTINAL PAIN 72
825 TENDON DISORDER 72
826 TRANSFUSION 72
827 CYANOSIS 71
828 METABOLIC ACIDOSIS 71
829 NERVE COMPRESSION 71
830 PERICARDIAL EFFUSION 71
831 PULMONARY FUNCTION TEST DECREASED 71
832 REBOUND EFFECT 71
833 SKIN WARM 71
834 WRONG PRODUCT ADMINISTERED 71
835 BLOOD CREATINE PHOSPHOKINASE INCREASED 70
836 HAEMATEMESIS 70
837 INFUSION SITE EXTRAVASATION 70
838 INTERVERTEBRAL DISC DEGENERATION 70
839 POISONING DELIBERATE 70
840 RESPIRATORY SYMPTOM 70
841 SOPOR 70
842 ACUTE RESPIRATORY DISTRESS SYNDROME 69
843 AGRANULOCYTOSIS 69
844 BLOOD PRESSURE DIASTOLIC ABNORMAL 69
845 CORONARY ARTERY DISEASE 69
846 FOOD POISONING 69
847 INFUSION SITE DISCHARGE 69
848 IRON DEFICIENCY ANAEMIA 69
849 SWELLING OF EYELID 69
850 TOOTHACHE 69
851 HALLUCINATIONS, MIXED 68
852 LEUKOCYTOSIS 68
853 OCULAR DISCOMFORT 68
854 HEMIPARESIS 67
855 PARANASAL SINUS DISCOMFORT 67
856 ROTATOR CUFF SYNDROME 67
857 BLOOD URIC ACID INCREASED 66
858 BONE DISORDER 66
859 DRUG DOSE OMISSION BY DEVICE 66
860 PARALYSIS 66
861 PIGMENTATION DISORDER 66
862 RALES 66
863 URTICARIA CHRONIC 66
864 BLOOD IRON DECREASED 65
865 CHOLECYSTITIS 65
866 CHOLECYSTITIS ACUTE 65
867 DRUG LEVEL INCREASED 65
868 GASTRIC ULCER 65
869 NASAL DRYNESS 65
870 OSTEITIS 65
871 PRODUCT USE COMPLAINT 65
872 RESPIRATORY ARREST 65
873 VICTIM OF CHEMICAL SUBMISSION 65
874 WRIST FRACTURE 65
875 BREAST MASS 64
876 LOOSE TOOTH 64
877 MENTAL IMPAIRMENT 64
878 WHEELCHAIR USER 64
879 BACTERIAL TEST POSITIVE 63
880 MATERNAL EXPOSURE DURING BREAST FEEDING 63
881 BONE LOSS 62
882 DEVICE DISLOCATION 62
883 GINGIVAL PAIN 62
884 HEPATITIS ACUTE 62
885 HYPERVENTILATION 62
886 INITIAL INSOMNIA 62
887 NEOPLASM PROGRESSION 62
888 OBSESSIVE-COMPULSIVE DISORDER 62
889 SINUS HEADACHE 62
890 SPINAL FRACTURE 62
891 SYNOVIAL CYST 62
892 VISUAL ACUITY REDUCED 62
893 APATHY 61
894 DEVICE RELATED INFECTION 61
895 EJECTION FRACTION DECREASED 61
896 HYPOTHERMIA 61
897 JOINT NOISE 61
898 TARDIVE DYSKINESIA 61
899 BASAL CELL CARCINOMA 60
900 DEVICE LEAKAGE 60
901 EXPOSURE VIA SKIN CONTACT 60
902 EYE INFECTION 60
903 FEELING DRUNK 60
904 PREMATURE BABY 60
905 SINUS BRADYCARDIA 60
906 SKIN SWELLING 60
907 THYROID DISORDER 60
908 URINE ANALYSIS ABNORMAL 60
909 APHTHOUS ULCER 59
910 ATRIAL SEPTAL DEFECT 59
911 BRUXISM 59
912 HERNIA 59
913 HYPOTONIA 59
914 RED CELL DISTRIBUTION WIDTH INCREASED 59
915 BRONCHIAL DISORDER 58
916 CARDIOMEGALY 58
917 INJECTION SITE WARMTH 58
918 SKIN CANCER 58
919 ASCITES 57
920 BLOOD PRESSURE SYSTOLIC ABNORMAL 57
921 DACTYLITIS 57
922 FIXED ERUPTION 57
923 FOOD INTOLERANCE 57
924 NEUTROPENIC SEPSIS 57
925 ORAL DISCOMFORT 57
926 AMYLOID ARTHROPATHY 56
927 CARDIOVASCULAR DISORDER 56
928 CHRONIC FATIGUE SYNDROME 56
929 DERMATITIS BULLOUS 56
930 DIABETES MELLITUS INADEQUATE CONTROL 56
931 DIABETIC KETOACIDOSIS 56
932 EYE DISCHARGE 56
933 HYPERPARATHYROIDISM SECONDARY 56
934 PRODUCT PRESCRIBING ISSUE 56
935 REBOUND ACID HYPERSECRETION 56
936 SKIN LACERATION 56
937 SUPRAVENTRICULAR TACHYCARDIA 56
938 VITAMIN B12 DECREASED 56
939 ANKLE ARTHROPLASTY 55
940 HAIR COLOUR CHANGES 55
941 MEAN CELL HAEMOGLOBIN DECREASED 55
942 NAIL OPERATION 55
943 PRODUCT DISTRIBUTION ISSUE 55
944 SENSITIVE SKIN 55
945 SKIN ABRASION 55
946 SPINAL OSTEOARTHRITIS 55
947 TONSILLITIS 55
948 VITAMIN B12 INCREASED 55
949 HEPATOMEGALY 54
950 MUSCULOSKELETAL DISORDER 54
951 PAROSMIA 54
952 PULMONARY ARTERIAL HYPERTENSION 54
953 SENSATION OF FOREIGN BODY 54
954 SENSORY LOSS 54
955 SNORING 54
956 BLOOD IMMUNOGLOBULIN A INCREASED 53
957 CONCUSSION 53
958 GYNAECOMASTIA 53
959 HYPERTHYROIDISM 53
960 INCREASED TENDENCY TO BRUISE 53
961 PEMPHIGOID 53
962 PERFUME SENSITIVITY 53
963 PRODUCT DISPENSING ERROR 53
964 RHEUMATOID FACTOR INCREASED 53
965 STREPTOCOCCAL INFECTION 53
966 URINE LEUKOCYTE ESTERASE POSITIVE 53
967 APPETITE DISORDER 52
968 ATELECTASIS 52
969 GLOMERULAR FILTRATION RATE INCREASED 52
970 HEART RATE ABNORMAL 52
971 INCORRECT DRUG ADMINISTRATION RATE 52
972 SJOGREN^S SYNDROME 52
973 TOOTH LOSS 52
974 CUTANEOUS VASCULITIS 51
975 DROOLING 51
976 EXERCISE TOLERANCE DECREASED 51
977 EYELID OEDEMA 51
978 GRANULOCYTE COUNT INCREASED 51
979 IMMUNE SYSTEM DISORDER 51
980 IMMUNE THROMBOCYTOPENIA 51
981 PNEUMOTHORAX 51
982 RESPIRATION ABNORMAL 51
983 SINUS PAIN 51
984 ABDOMINAL TENDERNESS 50
985 BOWEL MOVEMENT IRREGULARITY 50
986 BRAIN OEDEMA 50
987 BREAST CANCER STAGE I 50
988 ERUCTATION 50
989 POST CHOLECYSTECTOMY SYNDROME 50
990 PSEUDOMONAS INFECTION 50
991 RENAL PAIN 50
992 EYE INFLAMMATION 49
993 GENERALISED OEDEMA 49
994 LOCAL SWELLING 49
995 NASAL DISCHARGE DISCOLOURATION 49
996 NEUTROPHIL PERCENTAGE INCREASED 49
997 SCHIZOPHRENIA 49
998 ACUTE HEPATIC FAILURE 48
999 MYASTHENIA GRAVIS 48